Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Hickory › NPI 1376600718
Behavioral

Integrated Care of Greater Hickory, INC

Integrated Care of Greater Hickory, INC was paid $1.42M by Medicaid between Jan 2018 and Dec 2024, across 14 billing codes. Its largest line is H0015, Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education — 25% of everything it billed.

33Billing provider infoINTEGRATED CARE OF GREATER HICKORY, INC
HICKORY, NC 28602
33aNPI1376600718assigned 01/03/2007
28Total paid$1.42M
24GClaims25,147
24DCodes billed14
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Addiction (Substance Use Disorder) Counselor providers in North Carolina

Rank by total paid#47 of 222
Median peer was paid$168K
This provider vs. median8.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,656$598K
20191,128$78K
2020588$24K
2021685$24K
20222,743$127K
20234,322$193K
2024incomplete8,025$372K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H0015 Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education 25% 2,592 337 $358K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20% 5,740 2,692 $280K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 16% 1,271 642 $222K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 13% 2,945 1,322 $185K
90837 Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient 7.2% 1,415 585 $101K
90853 Group psychotherapy (other than of a multiple-family group) 5.2% 2,999 954 $73K
80305 3.9% 6,131 2,382 $55K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 3.6% 489 431 $52K
H0038 Self-help/peer services, per 15 minutes 3.4% 1,061 230 $48K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1.7% 180 116 $24K
90791 Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation <1% 133 115 $9K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity <1% 52 42 $4K
2 more codes
99214 Doctor's office visit, returning patient (more involved) <1% 24 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 115 $1K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBLAKEMAN, DOUGLAS (CAO-CHIEF ADMINISTRATIVE OFFICER)